---
figid: PMC6651655__ijms-20-03240-g003
figlink: /pmc/articles/PMC6651655/figure/ijms-20-03240-f003/
number: Figure 3
caption: Representation of S100B effects on Caco-2 cells. (A) S100B interacts at RAGE
  receptors and downstream activates p38/Akt signaling pathway leading to cell proliferation,
  increased release of cell migration and angiogenesis. (B) S100B effects are blocked
  by specific S100BmAb, as well as, RAGE specific antibody and p38/Akt inhibitor SB203580,
  leading to a significant control of angiogenesis and cell invasion in vitro.
pmcid: PMC6651655
papertitle: S100B Protein Stimulates Proliferation and Angiogenic Mediators Release
  through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 Cells.
reftext: Luisa Seguella, et al. Int J Mol Sci. 2019 Jul;20(13):3240.
pmc_ranked_result_index: '61000'
pathway_score: 0.9579639
filename: ijms-20-03240-g003.jpg
figtitle: Representation of S100B effects on Caco-2 cells
year: '2019'
organisms: Homo sapiens
ndex: 85e4b80b-dee4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6651655__ijms-20-03240-g003.html
  '@type': Dataset
  description: Representation of S100B effects on Caco-2 cells. (A) S100B interacts
    at RAGE receptors and downstream activates p38/Akt signaling pathway leading to
    cell proliferation, increased release of cell migration and angiogenesis. (B)
    S100B effects are blocked by specific S100BmAb, as well as, RAGE specific antibody
    and p38/Akt inhibitor SB203580, leading to a significant control of angiogenesis
    and cell invasion in vitro.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AGER
  - AKT2
  - ELL
  - S100B
  - AKT3
  - MTOR
  - NFKB1
  - VEGFD
  - PGF
  - VEGFA
  - MAP6
  - VEGFC
  - HIF1A
  - ARNT
  - AKT1
  - VEGFB
genes:
- word: RAGE
  symbol: RAGE
  source: hgnc_alias_symbol
  hgnc_symbol: AGER
  entrez: '177'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ell
  symbol: ELL
  source: hgnc_symbol
  hgnc_symbol: ELL
  entrez: '8178'
- word: S100B
  symbol: S100B
  source: hgnc_symbol
  hgnc_symbol: S100B
  entrez: '6285'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: ↑VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: ↑VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: ↑VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: STOP
  symbol: STOP
  source: hgnc_alias_symbol
  hgnc_symbol: MAP6
  entrez: '4135'
- word: ↑VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: HIF1@
  symbol: HIF1
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIF1@
  symbol: HIF1
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ↑VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
chemicals: []
diseases: []
---
